Annual Drug Patent Expirations for EPANED
Epaned is a drug marketed by Azurity and Silvergate Pharms and is included in two NDAs. It is available from one supplier. There are eleven patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for EPANED.
This drug has three patent family members in three countries.
The generic ingredient in EPANED is enalapril maleate. One supplier is listed for this compound. Additional details are available on the enalapril maleate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com